Previous 10 | Next 10 |
Teleflex Incorporated (TFX) Q1 2019 Earnings Conference Call May 2, 2019 08:00 AM ET Company Participants Jake Elguicze – Treasurer and Vice President of Investor Relations Liam Kelly – President and Chief Executive Officer Thomas Powell – Executive Vice Pres...
The following slide deck was published by Teleflex Incorporated in conjunction with their 2019 Q1 earnings Read more ...
Teleflex (NYSE: TFX ): Q1 Non-GAAP EPS of $2.24 beats by $0.07 ; GAAP EPS of $0.89. More news on: Teleflex Incorporated, Earnings news and commentary, Healthcare stocks news, Read more ...
First Quarter Revenues from Continuing Operations of $613.6 million, up 4.5% versus Prior Year Period; up 7.6% on a Constant Currency Basis First Quarter GAAP Diluted EPS from Continuing Operations of $0.89, down 24.6% versus Prior Year Period First Quarter Adjusted Diluted EP...
WAYNE, Pa., May 01, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced that new clinical data from numerous studies of the UroLift ® System for patients with benign prostatic hyperplasia (BPH) will be presented at the American Urological Association (AUA) ...
WAYNE, Pa., April 30, 2019 (GLOBE NEWSWIRE) -- Liam Kelly, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Bank of America Merrill Lynch 2019 Health Care Conference at the Encore Hotel in Las Vegas, Nevada, on Tuesday, May 14, 2019 at 4:20 p.m. (PT). ...
Neurocrine Biosciences (NASDAQ: NBIX ) initiated with Outperform rating and $113 (40% upside) price target at Evercore ISI. More news on: Neurocrine Biosciences, Inc., AcelRx Pharmaceuticals, Inc., Eli Lilly and Company, Healthcare stocks news, Stocks on the move, , Read more ...
WAYNE, Pa., April 18, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that financial results for the first quarter 2019 will be released before market open on Thursday, May 2, 2019. An investor conference call will be held at 8:00 a.m. (ET) on Thursday, May ...
WAYNE, Pa., March 26, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced the publication of its inaugural corporate social responsibility report, The JO IN Impact Report . The report ou...
Titan Medical Inc. (TSX: TMD) (Nasdaq: TMDI) (“Titan” or the “Company”) , a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (“MIS”) and Teleflex Incorporated (N...
News, Short Squeeze, Breakout and More Instantly...
WAYNE, Pa., July 31, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Ringer™ Perfusion Balloon Catheter (PBC), the only commercially available Perc...
WAYNE, Pa., July 29, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded two group purchasing agreements with Premier, Inc. Effective July 1, 2024, the Premier National Hemostasis Products and SURPASS® ...
WAYNE, Pa., July 24, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the establishment of the Teleflex Center for Antimicrobial Protection (TCAP) as a strategic branch of its Vascular Access business unit led by Chuck ...